US Bancorp
TSVT

US Bancorp’s 2seventy bio TSVT Stock Holding History

US Bancorp’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$385 – 4183
2024
Q2 		$385 Buy
+100
New +$451 ﹤0.01% 3880
2023
Q4 		– Sell
-2,402
Closed -$9.42K – 4154
2023
Q3 		$9.42K Sell
2,402
-126
-5% -$826 ﹤0.01% 3195
2023
Q2 		$25.6K Buy
2,528
+2,232
+754% +$23.6K ﹤0.01% 2855
2023
Q1 		$3.02K Buy
296
+28
+10% +$320 ﹤0.01% 3669
2022
Q4 		$2.51K Sell
268
-84
-24% -$1.19K ﹤0.01% 3717
2022
Q3 		$5K Sell
352
-318
-47% -$4.72K ﹤0.01% 3623
2022
Q2 		$9K Buy
670
+154
+30% +$2.1K ﹤0.01% 3401
2022
Q1 		$9K Buy
516
+101
+24% +$1.71K ﹤0.01% 3423
2021
Q4 		$11K Buy
+415
New +$12.9K ﹤0.01% 3398

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

US Bancorp's TSVT Position: Q3 2024 in Review

US Bancorp sold out of 2seventy bio (TSVT) in Q3 2024, closing a stake of 100 shares — an estimated $385 sold.

US Bancorp first reported a position in TSVT in Q4 2021 and held it in 9 quarters. The position peaked at $25.6K in Q2 2023. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • US Bancorp reported no remaining 2seventy bio position as of Q3 2024 after selling out during the quarter.
  • US Bancorp sold 100 2seventy bio shares in Q3 2024, an estimated $385.
  • US Bancorp first reported a position in 2seventy bio in Q4 2021 and held it in 9 quarters.
  • US Bancorp's 2seventy bio position peaked at $25.6K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.